125 related articles for article (PubMed ID: 12191693)
1. Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability.
Jumaa M; Müller BW
Eur J Pharm Biopharm; 2002 Sep; 54(2):207-12. PubMed ID: 12191693
[TBL] [Abstract][Full Text] [Related]
2. The influence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modified with solutol HS 15.
Buszello K; Harnisch S; Müller RH; Müller BW
Eur J Pharm Biopharm; 2000 Mar; 49(2):143-9. PubMed ID: 10704897
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of polysaccharides on the stability of parenteral emulsions.
Chai G; Sun F; Shi J; Tian B; Tang X
Drug Dev Ind Pharm; 2013 May; 39(5):646-56. PubMed ID: 22583006
[TBL] [Abstract][Full Text] [Related]
4. Effect of inorganic additives on solutions of nonionic surfactants V: Emulsion stability.
Schott H; Royce AE
J Pharm Sci; 1983 Dec; 72(12):1427-36. PubMed ID: 6663480
[TBL] [Abstract][Full Text] [Related]
5. Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.
Paul S; Kumar A; Yedurkar P; Sawant K
Drug Dev Ind Pharm; 2013 Nov; 39(11):1809-17. PubMed ID: 23281917
[TBL] [Abstract][Full Text] [Related]
6. Naproxen incorporated lipid emulsions. I. Formulation and stability studies.
Nasirideen S; Kaş HS; Oner F; Alpar R; Hincal AA
J Clin Pharm Ther; 1998 Feb; 23(1):57-65. PubMed ID: 9756113
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene glycol) hydroxystearate-based nanosized emulsions: effect of surfactant concentration on their formation and ability to solubilize quercetin.
Dora CL; Silva LF; Putaux JL; Nishiyama Y; Pignot-Paintrand I; Borsali R; Lemos-Senna E
J Biomed Nanotechnol; 2012 Apr; 8(2):202-10. PubMed ID: 22515071
[TBL] [Abstract][Full Text] [Related]
8. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier.
Vasiljevic D; Parojcic J; Primorac M; Vuleta G
Int J Pharm; 2006 Feb; 309(1-2):171-7. PubMed ID: 16406403
[TBL] [Abstract][Full Text] [Related]
9. Influence of protein emulsifier interfacial properties on oil-in-water emulsion stability.
Burgess DJ; Sahin ON
Pharm Dev Technol; 1998 Feb; 3(1):21-9. PubMed ID: 9532597
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the applicability of HLB values for natural phospholipid emulsifiers for preparation of stable emulsions.
Otto F; van Hoogevest P; Syrowatka F; Heinl V; Neubert RHH
Pharmazie; 2020 Aug; 75(8):365-370. PubMed ID: 32758334
[TBL] [Abstract][Full Text] [Related]
11. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification.
Oh DH; Balakrishnan P; Oh YK; Kim DD; Yong CS; Choi HG
Int J Pharm; 2011 Feb; 404(1-2):191-7. PubMed ID: 21055456
[TBL] [Abstract][Full Text] [Related]
12. Effect of terminal heat sterilization on the stability of phospholipid-stabilized submicron emulsions.
Chaturvedi PR; Patel NM; Lodhi SA
Acta Pharm Nord; 1992; 4(1):51-5. PubMed ID: 1515053
[TBL] [Abstract][Full Text] [Related]
13. The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion.
Hung CF; Fang CL; Liao MH; Fang JY
Int J Pharm; 2007 Apr; 335(1-2):193-202. PubMed ID: 17129692
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel parenteral formulation for tetrazepam using a lipid emulsion.
Jumaa M; Müller BW
Drug Dev Ind Pharm; 2001 Nov; 27(10):1115-21. PubMed ID: 11794814
[TBL] [Abstract][Full Text] [Related]
15. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
16. Onion phases of PEG-8 distearate.
Redkar M; Hassan PA; Aswal V; Devarajan P
J Pharm Sci; 2007 Sep; 96(9):2436-45. PubMed ID: 17506510
[TBL] [Abstract][Full Text] [Related]
17. Development of Clotrimazole Multiple W/O/W Emulsions as Vehicles for Drug Delivery: Effects of Additives on Emulsion Stability.
Suñer J; Calpena AC; Clares B; Cañadas C; Halbaut L
AAPS PharmSciTech; 2017 Feb; 18(2):539-550. PubMed ID: 27126008
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanocapsules containing the non-ionic surfactant Solutol HS15 inhibit the transport of calcium through hyperforin-activated channels in neuronal cells.
Chauvet S; Barras A; Boukherroub R; Bouron A
Neuropharmacology; 2015 Dec; 99():726-34. PubMed ID: 26341818
[TBL] [Abstract][Full Text] [Related]
19. The physicochemical characterization and in vitro/in vivo evaluation of natural surfactants-based emulsions as vehicles for diclofenac diethylamine.
Vucinić-Milanković N; Savić S; Vuleta G; Vucinić S
Drug Dev Ind Pharm; 2007 Mar; 33(3):221-34. PubMed ID: 17454055
[TBL] [Abstract][Full Text] [Related]
20. Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system.
Kan P; Chen ZB; Lee CJ; Chu IM
J Control Release; 1999 Apr; 58(3):271-8. PubMed ID: 10099152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
